Plasma Cell MyelomaPhase 2NCT05208307
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
Belantamab Mafodotin, Dexamethasone, Pomalidomide
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Plasma Cell MyelomaPhase 2NCT05208307
Belantamab Mafodotin, Dexamethasone, Pomalidomide
Multiple Myeloma in RelapsePhase 2NCT06822972
Selinexor 40 mg
Folliculotropic Mycosis FungoidesPhase 2NCT04930653
Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment, Questionnaire Administration
IDH1 MutationPhase 2NCT07471841
Olutasidenib, Azacitidine (AZA)
Relapsed or Refractory Acute Myeloid LeukemiaPhase 1NCT07025564Papers
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Waldenstrom MacroglobulinemiaPhase 2NCT06561347
Zanubrutinib, Bendamustine, Rituximab
Refractory Multiple MyelomaPhase 2NCT06138275
Elranatamab
Newly Diagnosed Acute Myeloid LeukemiaPhase 1NCT07177079
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Hodgkin LymphomaPhase 2NCT07551583
Nivolumab, Doxorubicin Hydrochloride, Vinblastine, Dacarbazine
Chronic Lymphocytic LeukemiaPhase 2NCT07734038
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
Acute Myeloid LeukemiaPhase 1NCT06152809
CIML NK Cells With Venetoclax for AML
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPhase 2NCT07365306
Autologous Hematopoietic Stem Cell Transplantation, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration
Recurrent Diffuse Large B-Cell LymphomaPhase 2NCT06784726
Odronextamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
Multiple MyelomaPhase 2NCT05344833
Isatuximab, Lenalidomide
Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMMLPhase 1/2NCT06523556
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Ann Arbor Stage II Follicular LymphomaPhase 2NCT06442475
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Mosunetuzumab
NeoplasmsPhase 1NCT05836896Papers
Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies
Acute Myeloid LeukemiaPhase 2NCT06930352
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Cytarabine
Recurrent Multiple MyelomaPhase 2NCT06940297
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy
Acute Myeloid LeukemiaPhase 1NCT07439211
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
Multiple MyelomaPhase 2NCT07227311
Belantamab mafodotin, Dexamethasone, Pomalidomide, Bortezomib
Acute Myeloid Leukemia With Gene MutationsPhase 2NCT04493164
Ivosidenib, Liposome-encapsulated Daunorubicin-Cytarabine
Relapsed or Refractory Aggressive B-Cell LymphomaPhase 1/2NCT06536049
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma (DLBCL)Phase 2NCT06594939
Polatuzumab Vedotin, Mosunetuzumab, Cyclophosphamide, Doxorubicin